Healthcare Biomarkers Market By Product Analysis (Consumable, Software, Services); By Type Analysis (Safety biomarker, Validation biomarker, Efficacy biomarker); By Application Analysis (Diagnostics development, Personalized medicine, Drug discovery & development, Disease risk assessment); By Disease indication Analysis (Cancer, Neurological disorders, Cardiovascular disorders, Immunological disorders) and By Regional Analysis – Global Forecast by 2023-2028
The Global Healthcare Biomarkers Market is expected to be around US$ 116 billion by 2028 and will grow at a CAGR of more than 13% in the given forecast period.
COVID-19 Impact Analysis Report
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
13
REPORT DESCRIPTION
A biomarker refers to a biological molecule or gene that is used to efficiently and correctly evaluate pharmacologic responses, pathogenic approaches, and biological tactics. Also known as a molecular marker or signature molecule, biomarkers are located in blood, different frame fluids, and tissue. Drastically used to peer the frame’s response to a selected remedy for a disease or condition, biomarkers assist clinical specialists to take powerful clinical decisions and help in diagnosing the fitness of patients. The U.S. food and drug management has approved the usage of biomarkers as surrogate quit-factors in the remedy improvement process. Biomarkers play a pivotal role in ailment danger assessment, drug discovery and improvement, diagnostics improvement, personalized medicinal drug, and others. Research activities are especially focused on the development of diagnostics biomarkers for most cancers.
How Big is the Global Healthcare Biomarkers Market?
The Global Healthcare Biomarkers Market is expected to be around US$ 116 billion by 2028 and will grow at a CAGR of more than 13% in the given forecast period.
The major driving factors of Global Healthcare Biomarkers Market are as follows:
• Rise in number of cros and low down cost for conduct clinical trials in developing nations.
• Use of biomarkers in diagnostic procedure is enhancing rapidly.
• Increasing healthcare expenses and R&D funding.
The restraining factors of Global Healthcare Biomarkers Market are as follows:
• Technological issue associated to sample and storage.
• High investment and low cost and benefit ratio.
• High testing cost
The Global Healthcare Biomarkers Market is segmented on the lines of its product, type, application, disease indication and regional. Based on product segmentation it covers consumable, software and services. Type segmentation covers safety biomarker, validation biomarker and efficacy biomarker. The applications segmentation contains diagnostics development, personalized medicine, drug discovery & development and disease risk assessment. Under disease indication segmentation it covers cancer, neurological disorders, cardiovascular disorders and immunological disorders. The Global Healthcare Biomarkers Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Healthcare Biomarkers and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Healthcare Biomarkers.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Global Healthcare Biomarkers Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche Diagnostics Ltd., Abbott Laboratories, Inc., Agilent Technologies, Inc., Epigenomics AG, GE Healthcare, Johnson & Johnson, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH, Qiagen N.V., and Merck& Co., Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Healthcare Biomarkers Market has been segmented as below:
By Product Analysis
• Consumable
• Software
• Services
By Type Analysis
• Safety biomarker
• Validation biomarker
• Efficacy biomarker
By Application Analysis
• Diagnostics development
• Personalized medicine
• Drug discovery & development
• Disease risk assessment
By Disease indication Analysis
• Cancer
• Neurological disorders
• Cardiovascular disorders
• Immunological disorders
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global healthcare Biomarkers Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Healthcare Biomarkers Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology (Page No. - 17)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.3 Market Rank Estimation
2.4 Key Industry Insights
2.5 Assumptions for the Study
3 Executive Summary (Page No. - 25)
4 Premium Insights (Page No. - 29)
4.1 Biomarkers: Market Overview
4.2 Geographic Analysis: Biomarkers Market, By Product (2018)
4.3 Market, By Type, 2019 vs 2025
4.4 Market Size, By Application, 2019 vs 2025
4.5 Market, By Disease Indication, 2019 vs 2025
4.6 Market: Geographic Growth Opportunities
4.7 Life Cycle Analysis, By Region, 2019
5 Market Overview (Page No. - 34)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Diagnostic Applications of Biomarkers
5.2.1.1.1 Personalized Medicine
5.2.1.1.2 Companion Diagnostics
5.2.1.2 Increasing R&D Funding for Pharma and Biotech Companies
5.2.1.3 Increasing Number of Cros and Low Cost of Clinical Trials in Developing Countries
5.2.1.4 High Prevalence of Cancer
5.2.1.5 New Initiatives for Biomarker Research
5.2.2 Restraints
5.2.2.1 High Capital Investments and Low Cost-Benefit Ratio
5.2.2.2 Poorly Suited Regulatory and Reimbursement Systems
5.2.2.3 Technical Issues Related to Sample Collection and Storage
5.2.3 Opportunities
5.2.3.1 Emerging Economies
5.2.4 Challenges
5.2.4.1 Proving the Clinical Validity in Biomarker-Based Tests
6 Biomarkers Market, By Product (Page No. - 43)
6.1 Introduction
6.2 Consumables
6.3 Services
6.4 Software
7 Biomarkers Market, By Type (Page No. - 50)
7.1 Introduction
7.2 Safety Biomarkers
7.3 Efficacy Biomarkers
7.3.1 Predictive Biomarkers
7.3.2 Surrogate Biomarkers
7.3.3 Pharmacodynamic Biomarkers
7.3.4 Prognostic Biomarkers
7.4 Validation Biomarkers
8 Biomarkers Market, By Application (Page No. - 63)
8.1 Introduction
8.2 Diagnostics
8.3 Drug Discovery and Development
8.4 Personalized Medicine
8.5 Disease Risk Assessment
8.6 Other Applications
9 Biomarkers Market, By Disease Indication (Page No. - 76)
9.1 Introduction
9.2 Cancer
9.3 Cardiovascular Disorders
9.4 Neurological Disorders
9.5 Immunological Disorders
9.6 Other Diseases
10 Biomarkers Market, By Region (Page No. - 89)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia
10.4.1 China
10.4.2 Japan
10.4.3 Rest of Asia
10.5 Rest of the World (RoW)
11 Competitive Landscape (Page No. - 118)
11.1 Overview
11.2 Competitive Situation and Trends
11.2.1 Product Launches
11.2.2 Collaborations, Partnerships, and Agreements
11.2.3 Acquisitions
11.2.4 Other Developments
11.3 Leading Players in the Biomarkers Market
12 Company Profiles (Page No. - 124)
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 Qiagen N.V.
12.2 Perkinelmer, Inc.
12.3 Merck Millipore
12.4 Bio-Rad Laboratories, Inc.
12.5 Enzo Biochem, Inc.
12.6 EKF Diagnostics Holdings, Inc.
12.7 Meso Scale Diagnostics, LLC.
12.8 Biosims Technologies Sas
12.9 Cisbio Bioassays
12.10 Signosis, Inc.
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. - 146)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports
13.8 Author Details
The Global Healthcare Biomarkers Market has been segmented as below:
By Product Analysis
• Consumable
• Software
• Services
By Type Analysis
• Safety biomarker
• Validation biomarker
• Efficacy biomarker
By Application Analysis
• Diagnostics development
• Personalized medicine
• Drug discovery & development
• Disease risk assessment
By Disease indication Analysis
• Cancer
• Neurological disorders
• Cardiovascular disorders
• Immunological disorders
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
Got a question? We've got answers. If you have some other questions, see our support center.
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE